Top Markets
#1 Helium Helium +114.48%
#2 MowCat MowCat +88.56%
#3 Seeker Seeker +62.86%
#4 UnifAI Network UnifAI Network +35.32%
#5 TENDIES TENDIES +27.62%
#6 pipedog pipedog +23.28%
#7 Zylo Ecosystem Zylo Ecosystem +21.92%
#8 Pons Pons +21.85%
#9 Bounce Bounce +21.52%
#10 Tensor Tensor +21.02%
Coin of the day
Helium Helium
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
EQRx, Inc. EQRx, Inc.

EQRx, Inc.

EQRX
Classificação em ações #11212
EQRx, Inc. is a U.S.-based pharmaceutical firm dedicated to innovating... EQRx, Inc. is a U.S.-based pharmaceutical firm dedicated to innovating therapies, predominantly for oncological (cancer) and immune-inflammatory conditions. The company's late-stage pipeline features two promising drug candidates in Phase III clinical trials: Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor specifically for patients with EGFR-mutated non-small cell lung cancer (NSCLC), and Sugemalimab, an anti-programmed death-ligand 1 antibody aimed at treating Stage III and Stage IV NSCLC. Its broader developmental portfolio encompasses a range of additional clinical and pre-clinical assets. This portfolio includes Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor in Phase II trials for metastatic breast cancer; EQ176, an anti-programmed death-1 antibody undergoing Phase III development for primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor currently in various Phase I studies. Established in 2019, EQRx maintains its corporate headquarters in Cambridge, Massachusetts.
Preço da ação
$2.34
Última sincronização: 2023-11-09
Valor de mercado
$728.90M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar EQRx, Inc. (EQRX)

Categoria

Healthcare
EPS de EQRx, Inc. (EQRX)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da EQRx, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da EQRx, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH